News

Filter

1 to 9 of 18 results

Aventis and Watson settle over Dilacor

28-09-2001

Aventis and the USA's Watson Pharmaceuticals have settled a long-runningpatent infringement suit relating…

Aventis PharmaCardizem LADilacor XRDiltiazemDiltiazem Hydrochloride CapsuleExtended ReleaseWatson Pharmaceuticals

Andrx Submits ANDA For Bioequivalent Drugs

23-09-1998

The US Food and Drug Administration has accepted Abbreviated New DrugApplication submissions from Andrx…

AnaproxAnaprox DSCardizem LADilacor XRDiltiazemDiltiazem HclDiltiazem Hydrochloride CapsuleExtended ReleaseNaprelanNaprosynNaproxenNaproxen SodiumTiazacWyeth

SkyePharma Benefits From Lilly Trial Advance

15-05-1998

UK drug-delivery company SkyePharma has confirmed that USpharmaceutical major Eli Lilly has initiated…

Abbott LaboratoriesCardizem LACeclorCefaclorDilacor XRDiltiazemDiltiazem Hydrochloride CapsuleDoparEvistaExtended ReleaseLevodopaLillyparoxetinePaxilRaloxifeneRocheZileutinZyflo

FDA Advisory C'tee Recommendation For R-PR's Lovenox

03-07-1997

Franco-American firm Rhone-Poulenc Rorer says the US Food and DrugAdministration's Cardiovascular and…

AspirinBayerCardizem LADilacor XRDiltiazemDiltiazem Hydrochloride CapsuleEnoxaparin Sodium InjectionExtended ReleaseheparinLovenoxWatson Pharmaceuticals

R-PR Gets US Approval For Nasacort AQ

16-10-1995

Rhone-Poulenc Rorer has received an approvable letter from the US Food and Drug Administration for Nasacort…

AzmacortCardizem LADilacor XRDiltiazemDiltiazem Hydrochloride CapsuleExtended ReleaseNasacort AQTriamcinolone Acetonide

Watson Offers $606.5 Million For Circa

10-04-1995

US-based generic drugmaker Watson has made a $606.5 million offer to acquire Circa (formerly Bolar Pharmaceuticals),…

Cardizem LADilacor XRDiltiazemDiltiazem Hydrochloride CapsuleEldeprylExtended ReleaseGlipizideGlucotrolMiconazoleMonistat-DermNitro-DurNitroglycerinNitrostatPseudoephedrineSelegiline HclSudafedTransderm Nitro

1 to 9 of 18 results

COMPANY SPOTLIGHT

Menarini

Back to top